🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christina Bellinger

Atrium Health Wake Forest Baptist

ORCID: 0000-0002-6648-8251

Also affiliated with Wake Forest University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.379Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates

Frontiers in Oncology(2021)10.3389/fonc.2021.584896
Top 48%
0.379DataRank
Top 48%5 citations

Lynn S. Huang, Ryan Barnard, Graham Parks, James O. Cappellari, Christina Bellinger +11 more

Papers

Driven by 7 papers — median percentile 52. Top paper: “A Direct-to-Patient Digital Health Program for Lung Cancer Screening”.

A Direct-to-Patient Digital Health Program for Lung Cancer Screening

JAMA(2025)10.1001/jama.2025.17281
N/A
0.389DataRank · unranked
10 citations

Anna C. Snavely, Ajay Dharod, Alison T. Brenner, Elena Wright, Lindsay R. Stradtman +8 more

Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates

Frontiers in Oncology(2021)10.3389/fonc.2021.584896
Top 48%
0.379DataRank
Top 48%5 citations

Lynn S. Huang, Ryan Barnard, Graham Parks, James O. Cappellari, Christina Bellinger +11 more

The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer

Contemporary Clinical Trials(2020)10.1016/j.cct.2020.105963
N/A
0DataRank · unranked
16 citations

David P. Miller, Kathryn E. Weaver, Erin L. Sutfin, W. Jeffrey Petty, Christina Bellinger +8 more

Comparing characteristics of individuals screened for lung cancer with 2021 vs 2013 US Preventive Services Task Force recommendations

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae141
N/A
0DataRank · unranked
4 citations

Danielle D. Durham, James F. Gruden, Michael P. Pritchard, Lindsay Lane, Jason M. Long +3 more

Comparing characteristics of individuals screened for lung cancer with 2021 vs 2013 US Preventive Services Task Force recommendations

UNC Libraries(2025)10.17615/11e9-wg43
N/A
0DataRank · unranked
0 citations

Danielle D. Durham, Lindsay Lane, Christina Bellinger, Michael P. Pritchard, Jason M. Long +3 more

Effect of an artificial intelligence tool on management decisions for indeterminate pulmonary nodules

Respirology(2023)10.1111/resp.14502
N/A
0DataRank · unranked
7 citations

Jason Oke, Travis Dotson, Christina Bellinger, Anil Vachani, Roger Y. Kim

Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10

Cancers(2020)10.3390/cancers12040788
N/A
0DataRank · unranked
28 citations

Lance D. Miller, Jeff W. Chou, Anthony Dominijanni, Lysette Mutkus, Frank C. Marini +6 more